Skip to search formSkip to main contentSkip to account menu

2 ML Dexmedetomidine 0.1 MG/ML Injection

Known as: DEXMEDETOMIDINE HCL 100MCG/ML INJ [VA Product], Dexmedetomidine Hydrochloride 100 ug in 1 mL INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE [Dexmedetomidine], DEXMEDETOMIDINE HYDROCHLORIDE 100 ug in 1 mL INTRAVENOUS INJECTION, SOLUTION 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Dexmedetomidine is a hepatically eliminated drug with sedative, anxiolytic, sympatholytic, and analgesic properties that has been… 
2019
2019
Dexmedetomidine has been a preferred sedative for patients undergoing regional anaesthesia and is mostly administered via… 
2018
2018
Alpha‐2 agonists are direct peripheral vasoconstrictors, which achieve these effects by activating vascular smooth muscle alpha‐2… 
2017
2017
Dexmedetomidine (DEX) is a fairly new alfa2-agonist which has been increasingly used in recent years for analgosedation, mostly… 
2017
2017
Objectives The aim of the study was to evaluate the cardiorespiratory effects, quality of sedation and recovery of intramuscular… 
2017
2017
We compared anesthetic features, blood parameters, and physiological responses to either medetomidine-tiletamine-zolazepam or… 
Review
2016
Review
2016
OBJECTIVE To assess the effects and utility of dexmedetomidine combined with tiletamine and zolazepam (dexMTZ) to immobilize the… 
2007
2007
To the Editor: In their editorial that accompanied four articles on dexmedetomidine use in children, Drs. Tobin, Shafer, and…